Skip to main content

Table 4 Antineoplastic treatment effect on BMD and BMC based on oral calcium and vitamin D3 supplementation in breast cancer patients (n = 40)

From: Antineoplastic treatment effect on bone mineral density in Mexican breast cancer patients

Parameter

No calcium supplement (n = 30)

Calcium supplement (n = 10)b

βa

p

Confidence Interval

95 %

βa

p

Confidence Interval

95 %

BMD femoral neck (g/cm2)

−0.03

<0.001

(−0.036, −0.024)

0.006

0.344

(−0.007, 0.018)

BMD L2-L4 (g/cm2)

−0.055

<0.001

(−0.076, −0.035)

−0.033

0.003

(−0.052, −0.013)

BMC (kg)

−0.047

0.039

(−0.092, −0.003)

<0.001

0.987

(−0,052, 0.052)

  1. BMD Bone Mineral Density, BMC Bone Mineral Content
  2. aDetermined by mixed model regression for repeated measures. Calcium supplement and treatment interaction (p ≤ 0.05)
  3. bCalcium and vitamin D3 supplementation (600 mg/200 IU day)